Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid

Acta Derm Venereol. 2018 Feb 7;98(2):284-286. doi: 10.2340/00015555-2845.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Autoantibodies / blood
  • Autoantigens / immunology
  • Biomarkers / blood
  • Biopsy
  • Collagen Type XVII
  • Dystonin / immunology
  • Female
  • Fluorescent Antibody Technique
  • Humans
  • Immunoglobulin E / blood
  • Immunologic Factors / therapeutic use*
  • Non-Fibrillar Collagens / immunology
  • Omalizumab / therapeutic use*
  • Pemphigoid, Bullous / blood
  • Pemphigoid, Bullous / diagnosis
  • Pemphigoid, Bullous / drug therapy*
  • Pemphigoid, Bullous / immunology
  • Remission Induction
  • Severity of Illness Index
  • Skin / drug effects*
  • Skin / immunology
  • Skin / pathology
  • Treatment Outcome

Substances

  • Autoantibodies
  • Autoantigens
  • Biomarkers
  • DST protein, human
  • Dystonin
  • Immunologic Factors
  • Non-Fibrillar Collagens
  • Omalizumab
  • Immunoglobulin E